Zealand Pharma A/S hired a senior executive from Eli Lilly & Co. after an agreement with a major drugmaker helped bolster its ambitions in obesity.

Switzerland's Xlife Sciences AG said on Wednesday its portfolio company, VERAXA Biotech AG, will merge with Voyager Acquisition in a deal that will value the combined company at $1.64 billion.

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...

The Trump administration is kicking off investigations into imports of pharmaceuticals and semiconductors as part of a bid to impose tariffs on both sectors on national security grounds, notices ...

The Trump administration disclosed that it had formally opened an investigation into the extent to which the importation of ...